Developer docs
API playgroundTry for free, no card

Search company profiles

Samsung Medical Center

Full company profile

uuid0006xfs

Namestring
Samsung Medical Center
Legal namestring
Samsung Medical Center (삼성서울병원)
Company typeenum
Private
Founded yearint
1994
Descriptiontext

Samsung Medical Center (삼성서울병원), founded in 1994 in Seoul's Gangnam district, is a tertiary care academic medical center operating within the Samsung Group conglomerate and affiliated with Sungkyunkwan University School of Medicine. It delivers comprehensive inpatient and outpatient services across more than 40 departments and runs dedicated specialized hospitals for cancer, cardiovascular and cerebrovascular care, health screening, and proton therapy, supported by a network of wholly-owned affiliates including Kangbuk Samsung Hospital and Samsung Changwon Hospital. The institution ranks #1 in Asia-Pacific for oncology, pulmonology, and gastroenterology in the 2026 Newsweek/Statista rankings and has achieved HIMSS INFRAM Stage 7 plus the world's first HIMSS CCMM Stage 6 certification, signaling a mature smart-hospital infrastructure.

The technology backbone centers on AI-ready clinical systems, advanced medical data platforms, and a pipeline of AI-driven diagnostic and therapeutic capabilities. Notable proprietary initiatives include the AURORA Lab for AI surgical robot development (lead role in a Ministry of Health and Welfare consortium with ~10 billion won in funding through 2030), an AI Star Fellow consortium with KAIST for disease-reasoning models, a Raman-spectroscopy CSF diagnostic platform validated at 90.8% accuracy, and a wireless ultrasound-driven electroceutical device for non-pharmacological pain relief. Research output includes a Nature whole-genome breast cancer study (1,364 genomes) and a Sleep-journal publication analyzing wearable data from 274,128 U.S. adults, indicating access to large-scale clinical and consumer health datasets.

Commercially, Samsung Medical Center generates revenue primarily through South Korea's National Health Insurance plus private-pay services for non-covered treatments, with additional streams from international medical tourism, health-screening programs, and clinical research services (including A-CRO drug development support). Distribution is anchored to its single Seoul campus operating 365 days with 24-hour emergency services, supplemented by referral partnerships, academic symposia, and digital patient engagement channels. The hospital does not publicly disclose pricing or revenue figures.

Short descriptiontext

Samsung Medical Center is a Seoul-based tertiary academic hospital and Samsung Group affiliate delivering comprehensive inpatient, outpatient, and specialty care across cancer, cardiovascular, and proton therapy centers. It combines advanced smart-hospital infrastructure with AI-driven diagnostic, surgical, and drug-discovery research collaborations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersYeoksamdong, South Korea
HQ citystring
Yeoksamdong
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
tertiary hospital services, cancer treatment services, cardiovascular care, proton therapy treatment, preventive health screening
Industry1 code
1Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryYes
NAICS code3 codes
  • General Medical and Surgical Hospitals62211
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • General Medical and Surgical Hospitals622110
SIC code3 codes
  • Services-Health Services8000
  • Services-Hospitals8060
  • Services-General Medical & Surgical Hospitals, Nec8062
Product category
Tertiary Hospital and Specialty Healthcare Services
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 6 records shown
1Cancer Hospital (암병원)
Description

Specialized cancer treatment center with multiple cancer-specific centers including liver, brain tumor, colorectal, head and neck, gynecologic, urological, gastric, breast, pancreatic/biliary, rare cancer, lung/esophageal, and blood cancer centers

samsunghospital.com
+5 more records
Core offering1 text field

Samsung Medical Center operates a comprehensive tertiary hospital providing inpatient and outpatient medical care across all major specialties, anchored by specialized hospitals for cancer, cardiovascular and cerebrovascular disease, proton therapy, and a preventive health screening center. It also delivers organ transplantation, emergency, intensive care, palliative/home care, and clinical research services, while serving as a research platform for AI-driven diagnostics, surgical robotics, and precision oncology through affiliations with Samsung Group entities and Korean academic partners.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Samsung Medical Center (Samsung Seoul Hospital) is a comprehensive medical center offering a multi-specialty hospital structure with specialized hospitals and centers. The portfolio includes the general Samsung Seoul Hospital with all core medical departments, the specialized Cancer Hospital with 14+ cancer-specific treatment centers, the Cardiovascular and Cerebrovascular Hospital, the Health Medicine Center for preventive care, and the Proton Therapy Center for advanced radiation treatment. Additional services include specialized centers for brain/nerve, transplant, intensive care, emergency, and palliative care, plus the Future Medical Research Institute for innovation and the Clinical Research Center for trials. The institution is part of the Samsung medical network including Kangbuk Samsung Hospital and Samsung Changwon Hospital.

Product and service10 records
1Samsung Seoul Hospital (삼성서울병원)
CategoryGeneral Hospital Services
Description

Comprehensive tertiary hospital providing general and specialized inpatient and outpatient medical care across all major departments, including internal medicine, surgery, and pediatrics, with subspecialty centers for cancer, cardiovascular, neurological, and other complex conditions.

2Cancer Hospital (암병원)
CategorySpecialty Oncology Services
Description

Specialized cancer treatment center with 14+ cancer-specific centers covering liver, brain tumor, colorectal, head and neck, gynecologic, urological, gastric, breast, pancreatic/biliary, rare cancer, lung/esophageal, and blood cancers, plus radiation oncology and proton therapy.

3Cardiovascular and Cerebrovascular Hospital (심장뇌혈관병원)
CategorySpecialty Cardiovascular Services
Description

Specialized hospital for heart and cerebrovascular diseases featuring a cardiac center, arrhythmia center, stroke center, vascular center, preventive rehabilitation center, and imaging center.

4Health Medicine Center (건강의학센터)
CategoryPreventive Health Screening
Description

Preventive health examination and wellness center offering comprehensive multi-system checkup programs and健康管理 (health management) services for individuals and corporate clients.

5Proton Therapy Center (양성자치료센터)
CategoryAdvanced Radiation Oncology
Description

Advanced proton beam therapy facility providing precise radiation treatment for cancer patients.

6Future Medical Research Institute (미래의학연구원)
CategoryMedical Research and Innovation
Description

Research institute dedicated to pioneering medical research and innovation, supporting advanced medical science development at the hospital.

7Specialized Centers (Brain/Nerve, ICU, Emergency, Palliative, Home Care)
CategorySpecialty Clinical Services
Description

Targeted specialty service lines including the Brain and Nerve Center, Intensive Care Unit, Home Care Center, Emergency Center, and Palliative Care Center.

8Organ Transplant Center (장기이식센터)
CategoryTransplant Services
Description

Comprehensive organ transplantation services including heart transplantation and other solid organ transplant procedures.

9Clinical Research Center (임상의학연구소)
CategoryClinical Trials and CRO Services
Description

Research center conducting clinical trials and supporting medical research with A-CRO (academic contract research organization) services for drug development.

10SMC Partner Center (SMC파트너즈센터)
CategoryReferral Network Services
Description

Referral partner network center facilitating medical referrals and partnerships with other healthcare institutions.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-06-27
Description

Joint research team published study in journal 'Sleep' analyzing sleep data from 274,128 U.S. adults wearing Samsung Galaxy Watches. Study found individual sleep needs vary significantly (6.5 to 9 hours), challenging the widely held recommendation that everyone needs 7-8 hours of sleep.

2Nine-institution consortium for wearable exoskeleton
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-06-26
Description

Nine-institution consortium including DGIST, KAIST, Seoul National University Hospital, Gangnam Severance Hospital, Samsung Medical Center, and Pusan National University Hospital. Severance Hospital leads a seven-year government-funded project to develop a wearable exoskeleton using AI to read brain signals from quadriplegic patients, with government funding of 20.25 billion won ($13 million) and total investment reaching about 30 billion won ($19 million).

mobihealthnews.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-01
Description

Samsung Bioepis and Samsung Medical Center signed a joint research agreement to collaborate on AI-driven drug research, establishing a consultative body and research advisory committee to carry out collaborative projects through 2030. Samsung Bioepis plans to leverage SMC's extensive medical data to develop AI-powered treatment technologies, build a platform for identifying novel drug targets, and support development of innovative therapeutics including antibody-drug conjugates.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-28
Description

Samsung Medical Center selected as lead organization for Ministry of Health and Welfare's AI-based surgical robot innovation project, receiving approximately 10 billion won in government funding over five years to build a development and validation framework for AI surgical robots. Collaboration with Rainbow Robotics, E-ROBE, Roen Surgical, Samsung Advanced Institute for Health Sciences and Technology, DGIST, and Tomorrow Robotics to establish the AURORA lab.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-05-10
Description

Researchers from Kyung Hee University Hospital at Gangdong and Samsung Medical Center studied over 1.3 million adults aged 40 and older without dementia from 2013 to 2024, finding that people with insulin-dependent diabetes face significantly higher dementia risk than those without diabetes.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-02-27
Description

Research team at Sungkyunkwan University in Seoul developed world's first AI-based optical diagnostic platform capable of distinguishing between nasal secretion and cerebrospinal fluid using Raman spectroscopy with AI-based machine learning. Platform achieved 90.8% diagnostic accuracy in identifying CSF leakage in clinical samples from Samsung Medical Center.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-01-12
Description

Joint research team from Yonsei University and Samsung Medical Center developed a wireless electroceutical device that uses ultrasound to generate triboelectricity in a biodegradable polymer, blocking nerve signals for pain relief without drugs, electrodes, or batteries. Preclinical trials demonstrated significant pain reduction with rapid nerve function recovery.

8Seoul St. Mary's Hospital and Inocras Inc.
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-03
Description

Research consortium led by Samsung Medical Center, Seoul St. Mary's Hospital, and Inocras Inc. published comprehensive whole-genome breast cancer study in Nature, analyzing 1,364 genomes and clinical data. Study identified biomarkers linked to treatment responses and prognosis, supporting precision oncology advancements.

pharmiweb.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-08-20
Description

Samsung Medical Center collaborated with Samsung Electronics on Galaxy Watch health sensors including enhanced ECG for ectopic beat detection, PPG for vascular load monitoring, and personalized Bedtime Guidance clinically validated at the medical center.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-23
Description

KAIST research team launched the 'AI Star Fellow Project' in collaboration with Samsung Medical Center, Naver Cloud, and HITS to develop AI models for disease reasoning, diagnosis, and new drug discovery, backed by 11.5 billion KRW in government funding through December 2030. The consortium plans to commercialize clinical diagnostic AI, AI-based molecular target exploration for drug development, and an expandable AI reasoning platform.

Peers10 records
TypeDirect peer
Description

Leading Korean academic medical center affiliated with Korea University, providing comparable tertiary care and specialty services. Direct competitor in the Seoul metropolitan market for complex patient care and clinical research.

TypeRegional player
Description

Leading medical tourism hospital in Bangkok, Thailand, and a major Asia-Pacific competitor for international patients seeking specialty care. Comparable in brand positioning for regional medical tourism but operates primarily in Southeast Asia.

TypeDirect peer
Description

One of the largest hospitals in Korea by bed capacity, also ranked among the top Asia-Pacific hospitals by Newsweek. Direct competitor for cancer care, organ transplantation, and cardiovascular services in the Seoul metropolitan area.

TypeRegional player
Description

Singapore's largest tertiary hospital and academic medical center, comparable in scale and specialty services. Regional Asia-Pacific peer competing for medical tourism and clinical research partnerships, though primarily serving the Singapore market.

TypeBroad incumbent
Description

Sister hospital within the Samsung medical network (wholly owned), serving the northern Seoul area. Provides general hospital services as part of the broader Samsung Group healthcare ecosystem alongside the flagship Samsung Medical Center.

6Seoul St. Mary's Hospital
TypeDirect peer
Description

Catholic University of Korea's flagship hospital, comparable academic medical center providing tertiary care and cancer services. Direct research partner with SMC on the Nature whole-genome breast cancer study and competes for similar patient demographics.

TypeDirect peer
Description

Korea's flagship national university hospital and academic medical center, providing comparable tertiary and quaternary care across all major specialties. Direct competitor for top physician talent, research funding, and complex patient referrals within the Korean market.

8Samsung Changwon Hospital
TypeBroad incumbent
Description

Sister hospital within the Samsung medical network (wholly owned), extending SMC's brand into the southeastern Korean market. Part of the broader Samsung hospital ecosystem but operates as a regional general hospital rather than a quaternary specialty center.

TypeDirect peer
Description

Yonsei University Health System's flagship hospital and a leading Korean academic medical center. Direct competitor in oncology, specialty care, and medical research; leads the wearable exoskeleton consortium that SMC participates in.

TypeDirect peer
Description

Seoul National University's secondary hospital in Bundang, providing similar tertiary care services with strong research capabilities. Competes with SMC for Gyeonggi province and greater Seoul patient populations.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Samsung Medical Center

Tertiary Hospital and Specialty Healthcare Servicessamsunghospital.com

Samsung Medical Center is a Seoul-based tertiary academic hospital and Samsung Group affiliate delivering comprehensive inpatient, outpatient, and specialty care across cancer, cardiovascular, and proton therapy centers. It combines advanced smart-hospital infrastructure with AI-driven diagnostic, surgical, and drug-discovery research collaborations.

What Samsung Medical Center does

Samsung Medical Center (삼성서울병원), founded in 1994 in Seoul's Gangnam district, is a tertiary care academic medical center operating within the Samsung Group conglomerate and affiliated with Sungkyunkwan University School of Medicine. It delivers comprehensive inpatient and outpatient services across more than 40 departments and runs dedicated specialized hospitals for cancer, cardiovascular and cerebrovascular care, health screening, and proton therapy, supported by a network of wholly-owned affiliates including Kangbuk Samsung Hospital and Samsung Changwon Hospital. The institution ranks #1 in Asia-Pacific for oncology, pulmonology, and gastroenterology in the 2026 Newsweek/Statista rankings and has achieved HIMSS INFRAM Stage 7 plus the world's first HIMSS CCMM Stage 6 certification, signaling a mature smart-hospital infrastructure.

The technology backbone centers on AI-ready clinical systems, advanced medical data platforms, and a pipeline of AI-driven diagnostic and therapeutic capabilities. Notable proprietary initiatives include the AURORA Lab for AI surgical robot development (lead role in a Ministry of Health and Welfare consortium with ~10 billion won in funding through 2030), an AI Star Fellow consortium with KAIST for disease-reasoning models, a Raman-spectroscopy CSF diagnostic platform validated at 90.8% accuracy, and a wireless ultrasound-driven electroceutical device for non-pharmacological pain relief. Research output includes a Nature whole-genome breast cancer study (1,364 genomes) and a Sleep-journal publication analyzing wearable data from 274,128 U.S. adults, indicating access to large-scale clinical and consumer health datasets.

Commercially, Samsung Medical Center generates revenue primarily through South Korea's National Health Insurance plus private-pay services for non-covered treatments, with additional streams from international medical tourism, health-screening programs, and clinical research services (including A-CRO drug development support). Distribution is anchored to its single Seoul campus operating 365 days with 24-hour emergency services, supplemented by referral partnerships, academic symposia, and digital patient engagement channels. The hospital does not publicly disclose pricing or revenue figures.

Samsung Medical Center firmographics

Firmographics
Name
Samsung Medical Center
Legal name
Samsung Medical Center (삼성서울병원)
Website
https://samsunghospital.com
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Samsung Medical Center is a Seoul-based tertiary academic hospital and Samsung Group affiliate delivering comprehensive inpatient, outpatient, and specialty care across cancer, cardiovascular, and proton therapy centers. It combines advanced smart-hospital infrastructure with AI-driven diagnostic, surgical, and drug-discovery research collaborations.
Ownership category
akta.pro rank

Samsung Medical Center industry classification

Industry
Product category
Tertiary Hospital and Specialty Healthcare Services
NAICS
General Medical and Surgical Hospitals (62211), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), General Medical and Surgical Hospitals (622110)
SIC
Services-Health Services (8000), Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)
akta.pro primary industry
Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

  • Tertiary hospital services
  • Cancer treatment services
  • Cardiovascular care
  • Proton therapy treatment
  • Preventive health screening

Where Samsung Medical Center is headquartered

Location

Headquarters

HQ city
Yeoksamdong
HQ country
South Korea
HQ region
Asia

Offices1 record

Markets served

Samsung Medical Center business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Distribution channels2 records

Marketing channels3 records

Samsung Medical Center product offering

Product offering

Core offering

Samsung Medical Center operates a comprehensive tertiary hospital providing inpatient and outpatient medical care across all major specialties, anchored by specialized hospitals for cancer, cardiovascular and cerebrovascular disease, proton therapy, and a preventive health screening center. It also delivers organ transplantation, emergency, intensive care, palliative/home care, and clinical research services, while serving as a research platform for AI-driven diagnostics, surgical robotics, and precision oncology through affiliations with Samsung Group entities and Korean academic partners.

Product overview

Samsung Medical Center (Samsung Seoul Hospital) is a comprehensive medical center offering a multi-specialty hospital structure with specialized hospitals and centers. The portfolio includes the general Samsung Seoul Hospital with all core medical departments, the specialized Cancer Hospital with 14+ cancer-specific treatment centers, the Cardiovascular and Cerebrovascular Hospital, the Health Medicine Center for preventive care, and the Proton Therapy Center for advanced radiation treatment. Additional services include specialized centers for brain/nerve, transplant, intensive care, emergency, and palliative care, plus the Future Medical Research Institute for innovation and the Clinical Research Center for trials. The institution is part of the Samsung medical network including Kangbuk Samsung Hospital and Samsung Changwon Hospital.

Differentiator

Problem solved

Functional benefit

Brands

  • Cancer Hospital (암병원): Specialized cancer treatment center with multiple cancer-specific centers including liver, brain tumor, colorectal, head and neck, gynecologic, urological, gastric, breast, pancreatic/biliary, rare cancer, lung/esophageal, and blood cancer centers
  • Cardiovascular Hospital (심장뇌혈관병원)
  • Health Promotion Center (건강의학센터)
  • Proton Therapy Center (양성자치료센터)
  • Future Medical Research Institute (미래의학연구원)
  • AURORA Lab

Products and services

  • Samsung Seoul Hospital (삼성서울병원) Comprehensive tertiary hospital providing general and specialized inpatient and outpatient medical care across all major departments, including internal medicine, surgery, and pediatrics, with subspecialty centers for cancer, cardiovascular, neurological, and other complex conditions.
  • Cancer Hospital (암병원) Specialized cancer treatment center with 14+ cancer-specific centers covering liver, brain tumor, colorectal, head and neck, gynecologic, urological, gastric, breast, pancreatic/biliary, rare cancer, lung/esophageal, and blood cancers, plus radiation oncology and proton therapy.
  • Cardiovascular and Cerebrovascular Hospital (심장뇌혈관병원) Specialized hospital for heart and cerebrovascular diseases featuring a cardiac center, arrhythmia center, stroke center, vascular center, preventive rehabilitation center, and imaging center.
  • Health Medicine Center (건강의학센터) Preventive health examination and wellness center offering comprehensive multi-system checkup programs and健康管理 (health management) services for individuals and corporate clients.
  • Proton Therapy Center (양성자치료센터) Advanced proton beam therapy facility providing precise radiation treatment for cancer patients.
  • Future Medical Research Institute (미래의학연구원) Research institute dedicated to pioneering medical research and innovation, supporting advanced medical science development at the hospital.
  • Specialized Centers (Brain/Nerve, ICU, Emergency, Palliative, Home Care) Targeted specialty service lines including the Brain and Nerve Center, Intensive Care Unit, Home Care Center, Emergency Center, and Palliative Care Center.
  • Organ Transplant Center (장기이식센터) Comprehensive organ transplantation services including heart transplantation and other solid organ transplant procedures.
  • Clinical Research Center (임상의학연구소) Research center conducting clinical trials and supporting medical research with A-CRO (academic contract research organization) services for drug development.
  • SMC Partner Center (SMC파트너즈센터) Referral partner network center facilitating medical referrals and partnerships with other healthcare institutions.

Companies that use Samsung Medical Center

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles3 records

Samsung Medical Center technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Samsung Medical Center partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered major and core.

  • Sungshin Women's University, Samsung Electronics, Harvard Medical SchoolmajorStrategic or Co-development Partner · 27 June 2026Joint research team published study in journal 'Sleep' analyzing sleep data from 274,128 U.S. adults wearing Samsung Galaxy Watches. Study found individual sleep needs vary significantly (6.5 to 9 hours), challenging the widely held recommendation that everyone needs 7-8 hours of sleep.
  • Nine-institution consortium for wearable exoskeletonmajorStrategic or Co-development Partner · 26 June 2026Nine-institution consortium including DGIST, KAIST, Seoul National University Hospital, Gangnam Severance Hospital, Samsung Medical Center, and Pusan National University Hospital. Severance Hospital leads a seven-year government-funded project to develop a wearable exoskeleton using AI to read brain signals from quadriplegic patients, with government funding of 20.25 billion won ($13 million) and total investment reaching about 30 billion won ($19 million).
  • Samsung BioepiscoreStrategic or Co-development Partner · 1 June 2026Samsung Bioepis and Samsung Medical Center signed a joint research agreement to collaborate on AI-driven drug research, establishing a consultative body and research advisory committee to carry out collaborative projects through 2030. Samsung Bioepis plans to leverage SMC's extensive medical data to develop AI-powered treatment technologies, build a platform for identifying novel drug targets, and support development of innovative therapeutics including antibody-drug conjugates.
  • Ministry of Health and WelfarecoreStrategic or Co-development Partner · 28 May 2026Samsung Medical Center selected as lead organization for Ministry of Health and Welfare's AI-based surgical robot innovation project, receiving approximately 10 billion won in government funding over five years to build a development and validation framework for AI surgical robots. Collaboration with Rainbow Robotics, E-ROBE, Roen Surgical, Samsung Advanced Institute for Health Sciences and Technology, DGIST, and Tomorrow Robotics to establish the AURORA lab.
  • Kyung Hee University Hospital at GangdongmajorStrategic or Co-development Partner · 10 May 2026Researchers from Kyung Hee University Hospital at Gangdong and Samsung Medical Center studied over 1.3 million adults aged 40 and older without dementia from 2013 to 2024, finding that people with insulin-dependent diabetes face significantly higher dementia risk than those without diabetes.
  • Sungkyunkwan UniversitymajorStrategic or Co-development Partner · 27 February 2026Research team at Sungkyunkwan University in Seoul developed world's first AI-based optical diagnostic platform capable of distinguishing between nasal secretion and cerebrospinal fluid using Raman spectroscopy with AI-based machine learning. Platform achieved 90.8% diagnostic accuracy in identifying CSF leakage in clinical samples from Samsung Medical Center.
  • Yonsei UniversitymajorStrategic or Co-development Partner · 12 January 2026Joint research team from Yonsei University and Samsung Medical Center developed a wireless electroceutical device that uses ultrasound to generate triboelectricity in a biodegradable polymer, blocking nerve signals for pain relief without drugs, electrodes, or batteries. Preclinical trials demonstrated significant pain reduction with rapid nerve function recovery.
  • Seoul St. Mary's Hospital and Inocras Inc.coreStrategic or Co-development Partner · 3 December 2025Research consortium led by Samsung Medical Center, Seoul St. Mary's Hospital, and Inocras Inc. published comprehensive whole-genome breast cancer study in Nature, analyzing 1,364 genomes and clinical data. Study identified biomarkers linked to treatment responses and prognosis, supporting precision oncology advancements.
  • Samsung ElectronicscoreTechnology or Integration · 20 August 2025Samsung Medical Center collaborated with Samsung Electronics on Galaxy Watch health sensors including enhanced ECG for ectopic beat detection, PPG for vascular load monitoring, and personalized Bedtime Guidance clinically validated at the medical center.
  • KAIST (Korea Advanced Institute of Science and Technology)coreStrategic or Co-development Partner · 23 May 2025KAIST research team launched the 'AI Star Fellow Project' in collaboration with Samsung Medical Center, Naver Cloud, and HITS to develop AI models for disease reasoning, diagnosis, and new drug discovery, backed by 11.5 billion KRW in government funding through December 2030. The consortium plans to commercialize clinical diagnostic AI, AI-based molecular target exploration for drug development, and an expandable AI reasoning platform.

Scale indicators5 records

Samsung Medical Center competitors and assessment

Company assessment

Direct peers

  • Korea University Anam Hospital: Leading Korean academic medical center affiliated with Korea University, providing comparable tertiary care and specialty services. Direct competitor in the Seoul metropolitan market for complex patient care and clinical research.
  • Asan Medical Center: One of the largest hospitals in Korea by bed capacity, also ranked among the top Asia-Pacific hospitals by Newsweek. Direct competitor for cancer care, organ transplantation, and cardiovascular services in the Seoul metropolitan area.
  • Seoul St. Mary's Hospital: Catholic University of Korea's flagship hospital, comparable academic medical center providing tertiary care and cancer services. Direct research partner with SMC on the Nature whole-genome breast cancer study and competes for similar patient demographics.
  • Seoul National University Hospital: Korea's flagship national university hospital and academic medical center, providing comparable tertiary and quaternary care across all major specialties. Direct competitor for top physician talent, research funding, and complex patient referrals within the Korean market.
  • Severance Hospital: Yonsei University Health System's flagship hospital and a leading Korean academic medical center. Direct competitor in oncology, specialty care, and medical research; leads the wearable exoskeleton consortium that SMC participates in.
  • Bundang Seoul National University Hospital: Seoul National University's secondary hospital in Bundang, providing similar tertiary care services with strong research capabilities. Competes with SMC for Gyeonggi province and greater Seoul patient populations.

Regional players

  • Bumrungrad International Hospital: Leading medical tourism hospital in Bangkok, Thailand, and a major Asia-Pacific competitor for international patients seeking specialty care. Comparable in brand positioning for regional medical tourism but operates primarily in Southeast Asia.
  • Singapore General Hospital: Singapore's largest tertiary hospital and academic medical center, comparable in scale and specialty services. Regional Asia-Pacific peer competing for medical tourism and clinical research partnerships, though primarily serving the Singapore market.

Broad incumbents

  • Kangbuk Samsung Hospital: Sister hospital within the Samsung medical network (wholly owned), serving the northern Seoul area. Provides general hospital services as part of the broader Samsung Group healthcare ecosystem alongside the flagship Samsung Medical Center.
  • Samsung Changwon Hospital: Sister hospital within the Samsung medical network (wholly owned), extending SMC's brand into the southeastern Korean market. Part of the broader Samsung hospital ecosystem but operates as a regional general hospital rather than a quaternary specialty center.

Market position

Strengths5 records

Weaknesses5 records

Key risks6 records

Key highlights7 records

Customer concentration

Samsung Medical Center social profiles

Digital presence

Samsung Medical Center financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Samsung Medical Center leadership team

Management profile

Number of profiles

Profiles2 records

Samsung Medical Center subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Samsung Medical Center funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Samsung Medical Center M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Samsung Medical Center

What does Samsung Medical Center do?

Samsung Medical Center operates a comprehensive tertiary hospital providing inpatient and outpatient medical care across all major specialties, anchored by specialized hospitals for cancer, cardiovascular and cerebrovascular disease, proton therapy, and a preventive health screening center. It also delivers organ transplantation, emergency, intensive care, palliative/home care, and clinical research services, while serving as a research platform for AI-driven diagnostics, surgical robotics, and precision oncology through affiliations with Samsung Group entities and Korean academic partners.

Is Samsung Medical Center a public or private company?

Samsung Medical Center is a private company. It is classified as corporate owned and is currently operating.

When was Samsung Medical Center founded?

Samsung Medical Center was founded in 1994. It employs 501 to 1,000 people.

Where is Samsung Medical Center based?

Samsung Medical Center is headquartered in Yeoksamdong, South Korea, in the Asia region.

Who are Samsung Medical Center's main competitors?

Direct peers on record are Korea University Anam Hospital, Asan Medical Center, Seoul St. Mary's Hospital, Seoul National University Hospital, Severance Hospital and Bundang Seoul National University Hospital. Regional players are Bumrungrad International Hospital and Singapore General Hospital. Broad incumbents are Kangbuk Samsung Hospital and Samsung Changwon Hospital.

Does Samsung Medical Center have an API?

No public API is recorded for Samsung Medical Center.

What industry is Samsung Medical Center in?

Samsung Medical Center's product category is Tertiary Hospital and Specialty Healthcare Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 62211 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MkStray Kids’ Felix donates $220,000 to children’s hospitals, UNICEFStray Kids member Felix donated 300 million won ($220,000) on his birthday to children's hospitals and UNICEF. He gave 100 million won each to Samsung Medical Center and Seoul National University Children's Hospital, and 50 million won each to Books International and the Korean Committee for UNICEF.The Korea HeraldStray Kids’ Felix donates W300m on birthday to help sick childrenStray Kids member Felix donated 300 million won ($221,204) on his birthday to support pediatric patients, vulnerable children, and Nepal flood relief. The funds went to Samsung Medical Center, Seoul National University Children's Hospital, Books International, and UNICEF Korea. He previously donated to similar causes in 2024 and 2025.KoreatimesStray Kids' Felix marks birthday with $220,000 donation to children, flood victimsStray Kids member Felix donated 300 million won ($220,000) on his birthday to support sick children and disaster relief. He gave 100 million won each to Samsung Medical Center and Seoul National University Children's Hospital, and 50 million won each to Books International and UNICEF Korea. The donations cover cancer treatment, pediatric care, picture books, and flood relief in Nepal.Healthcare IT News'Maturing' AI governance underpins Samsung Medical Center's smart hospital transformationSamsung Medical Center in South Korea was revalidated at Stage 7 of the HIMSS EMRAM, with its enterprise AI governance maturing under the Office of AX. The hospital's smart ward received a 4.23/5 user score, and it plans to expand AI services across clinical care and administration.Nate1 out of 5 stomach cancer surgeries is performed with a robot... Samsung Seoul Hospital proves its competitiveness: Nate NewsSamsung Medical Center reached 1,500 cumulative robotic stomach cancer surgeries, with 256 of 1,174 last year's cases robotic (22%). The hospital plans to introduce the Da Vinci 5 for gastrointestinal surgery, and its 5-year survival rate is 89.5%, above national and US averages.NateWhat if you crave at night? 'Late-night eating syndrome'... Don't hold back, here's what you should do first: Nate NewsNight Eating Syndrome is an eating disorder characterized by consuming more than 25% of daily calories after dinner or waking up to eat, affecting approximately 1.5% of the general population and linked to stress and irregular biological rhythms. Samsung Medical Center emphasizes that treatment requires correcting daytime habits and managing stress rather than simply resisting food at night. This approach aims to restore biological rhythms through regular eating, exercise, and sleep schedules to mitigate metabolic health risks.ChosunbizNight Eating Syndrome: Hormonal Disorder, Not Habit, Says Samsung Medical CenterSamsung Medical Center released a report on August 18 identifying night eating syndrome as a hormonal disorder driven by stress and imbalances in cortisol, serotonin, leptin, and ghrelin rather than mere habit. The condition affects approximately 1.5% of the general population and is associated with severe health risks including metabolic diseases and cardiovascular issues. Professor Park Heong-joon advised patients to maintain regular meal schedules and utilize stress-relief techniques to manage symptoms.ChosunbizNight Eating Syndrome: Medical Condition, Not HabitSamsung Medical Center experts advise that Night Eating Syndrome (NES) is a medical condition driven by stress and hormonal imbalances rather than a simple habit. The syndrome, recognized in the DSM-5, affects approximately 1.5% of the general population and involves consuming 25% or more of daily calories after dinner. It poses significant health risks including obesity, diabetes, and cardiovascular issues due to disrupted sleep and metabolic cycles.The Times of IndiaFDA clears hearing aid feature on Samsung Galaxy BudsSamsung announced that its Galaxy Buds Hearing Aid feature has received clearance from the US Food and Drug Administration (FDA), allowing compatible earbuds to function as over-the-counter hearing aids for users aged 18 and older. The technology, developed in collaboration with the National Acoustic Laboratories and Samsung Medical Center, is backed by clinical validation studies from multiple universities. This FDA-approved feature will be available on Galaxy Buds 3 Pro and Galaxy Buds 4 Pro devices in the US and select markets starting in Q4 2026.MashableSamsung Galaxy Buds Get Hearing Aid Support, Following Apple’s AirPods FeatureSamsung has received US FDA clearance for a new hearing aid feature and an in-built hearing test for its Galaxy Buds, allowing compatible earbuds to provide personalized sound amplification for users with mild to moderate hearing loss. The features, developed in collaboration with the National Acoustic Laboratories and Samsung Medical Centre, are scheduled to roll out to Galaxy Buds 3 Pro and 4 Pro models in the US and select approved markets in Q4 2026.